| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |